Tech Center 1600 • Art Units: 1612 1615 1616 1617
This examiner grants 84% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18707160 | BIOCOMPATIBLE COMPOSITE MATERIAL AND METHOD OF MAKING THE SAME | Non-Final OA | Bio Protectant Technologies, Inc. |
| 17786183 | Compound, Antimicrobial Deodorant Composition Comprising Same, and Method for Producing Same | Non-Final OA | LG Chem, Ltd. |
| 18290051 | NANOSTRUCTURE OR MICROSTRUCTURE AND METHOD FOR PRODUCING SAME | Non-Final OA | The University of Tokyo |
| 17622759 | METHOD FOR PREPARING DRUG-LOADED SILK FIBROIN NANOCAPSULE, AND PRODUCT THEREOF | Non-Final OA | ZHEJIANG UNIVERSITY |
| 18431725 | TREATMENT OF SEPSIS AND SEPTIC SHOCK | Non-Final OA | COMBIOXIN SA |
| 17917899 | CAROTENOID SOLUTIONS AND USES THEREOF | Non-Final OA | L.E.A.F. HOLDINGS GROUP LLC |
| 18004603 | FUNGICIDAL MIXTURES | Non-Final OA | Adama Makhteshim Ltd. |
| 18599800 | USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION | Non-Final OA | Allergan, Inc. |
| 18584867 | ARIPIPRAZOLE SUSTAINED-RELEASE MICROSPHERE AND PREPARATION METHOD THEREFOR | Non-Final OA | Zhuhai Livzon Microsphere Technology Co. Ltd. |
| 18325567 | SUSTAINED FORMULATION FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE CONTAINING NALTREXONE AND METHOD USING THE SAME | Final Rejection | INVENTAGE LAB INC. |
| 17918692 | DEFIBROTIDE TREATMENT FOR THE PREVENTION OF ORGAN REJECTION AND INJURY | Final Rejection | Jazz Pharmaceuticals Ireland Limited |
| 18557882 | ETONOGESTREL FORMULATION | Non-Final OA | MEDINCELL SA |
| 18553461 | METHODS FOR MANUFACTURING OF HIGHLY CONCENTRATED HYDROGELS | Non-Final OA | Vitrean Inc. |
| 18371995 | DELIVERY SYSTEM DEVICE AND METHOD FOR PHARMACEUTICAL IMPLANTATION FOR TIMED RELEASE | Final Rejection | CEMStar, LLC |
| 18224687 | IMPLANT FOR OVARIAN DECLINE AND METHODS OF MANUFACTURING AN IMPLANT FOR OVARIAN DECLINE | Final Rejection | Gameto, Inc |
| 18279410 | HERBICIDAL MIXTURES AND COMPOSITIONS AND METHODS OF USE | Non-Final OA | SBM DÉVELOPPEMENT SAS |
| 18021460 | PHARMACEUTICAL COMPOSITIONS COMPRISING IONIC LIQUIDS | Non-Final OA | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN |
| 18255163 | ENTERIC-COATED PELLET, METHOD FOR PREPARING SAME AND FORMULATION COMPRISING SAME | Non-Final OA | LIVZON PHARMACEUTICAL GROUP INC. |
| 18139024 | UNIT DOSE PHARMACEUTICAL OF A DRY POWDER OF ONE OR MORE GLUCOCORTICOID OR MINERALOCORTICOID FLUDROCORTISONE ACETATE AND/OR TRIAMCINOLONE ACETONIDE COMPRISED IN A SYRINGE | Non-Final OA | EYE CO PTY LTD |
| 18125378 | RE-OILED AND HYPER-OILED LECITHIN CARRIER VEHICLES | Non-Final OA | BIO-UP MIMETIC TECHNOLOGIES, INC. |
| 17629220 | COMPOSITION FOR PREVENTING THE FORMATION OF SEEDS IN FRUIT | Non-Final OA | UNIVERSITAT POLITÈCNICA DE VALÈNCIA |
| 17320757 | COMPOSITION FOR GROWTH STIMULATION AND RESISTANCE TO STRESS FACTORS FOR PLANTS OF THE CANNABACEAE FAMILY | Non-Final OA | PSIMOS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy